MISSION

healthy people, healthy planet

TECHNOLOGY ANALYSIS

TECHNOLOGY ANALYSIS | CORPORATE STRATEGY | M&A

I have participated in technology analysis and diligence to support of over $400M in acquisitions and internal development and deployment of novel biotechnology platforms and first-in-class products reviewed by FDA, USDA, EPA and USFWS regulators:

AquaBounty genetically engineered (GE) salmon, first GE food animal FDA approved for human consumption (partial acquisitions)

Oxitec engineered insects to fight infectious disease, invasive species, and agricultural pests ($160M acquisition)
Trans Ova Genetics leading provider of bovine reproductive technologies for food production ($110M acquisition)
ViaGen cloning for food and companion animals, as well as endangered species (Trans Ova Genetics acquisition) [press] black footed ferret - NYTimes.com | Przewalski's horse - CNN.com
Okanagan Specialty Fruits genetically engineered non-browning apples and other fruits ($41M acquisition)
EnviroFlight nutritious alternative protein feed using insect larvae (technology acquisition and joint venture)
BioPop biological and popular culture art and biobased consumer products (acquisition)
GenVec viral-based vaccine platform for humans and animals (acquisition)
Intrexon molecular vaccine and non-disclosed engineered cell therapy platforms
ActoGeniX (ActoBiotics™) engineered microbial human and food animal medicinal platform ($60M acquisition)
Genomatix proprietary software for promoter design for genetic and genomic engineering (acquisition)
ILH, formerly Codexis, protein production facility in Hungary (acquisition)
Intrexon’s UltraVector® protein engineering and gene switch platforms for clinical, industrial, and agricultural applications [microbes, plants, animals, humans]

Intrexon’s pioneering of gene-edited environmental systems for bioremediation of emerging contaminants of concern (COCs)

Tags: TECHNOLOGY ANALYSIS, CORPORATE STRATEGY, M&A, BIOTECHNOLOGY, NEW PRODUCT DEVELOPMENT

MISSION: HEALTHY PEOPLE, HEALTHY PLANET THE PUBLIC GOOD
The public good is often measured by the impact of our investments in making people healthier, protecting our environment, and ensuring the safety and security of our communities.

MISSION
I am currently focused on advising technology startups and establishing new ventures that contribute to the public good, healthier people, and a healthier planet.

TECHNOLOGY INNOVATIONS
My life has been filled with learning from exceptional groups working at the intersection of biotechnology and health. For over 25 years I have been driven through my research and industry work to build and advance solutions for complex problems impacting health globally. Biotechnology innovation and new product development underpin some of the most impactful public health interventions in recent generations. My world view has been shaped by developing, deploying and evaluating technologies applicable to individual healthcare, global public health, and environmental health.

GLOBAL PUBLIC HEALTH
I’m dedicated to realizing a shared vision and planetary view that the biosecurity, health and well-being of humans, animals and ecosystems - is interconnected. 'One Health' is a term that describes this interconnectedness. 'Planetary Health' does the same, if not more so.

VISION
We can realize better lives now and for generations to come with technologies developed to intentionally address the public good and promote healthier people and a healthier planet.

Learn more below about my current activities and the experiences that catalyzed my personal mission and informed my world view.

NEW PRODUCT DEVELOPMENT
PUBLIC HEALTH
GLOBAL HEALTH
M&A
TECHNOLOGY ANALYSIS
CORPORATE STRATEGY
BIOTECHNOLOGY
NATIONAL SECURITY
BIOSECURITY
ENVIRONMENT
BASIC RESEARCH
ACADEMIC RESEARCH
COMMUNITY HEALTH